Business ❯ Economics ❯ Industry ❯ Pharmaceuticals

Manufacturing

Trump Announces 100% Tariff on Branded Drug Imports, With Carve-Out for Firms Building U.S. Plants

The exemption for companies building U.S. plants leaves implementation unclear.

Eli Lilly Chooses Houston for $6.5 Billion Plant to Produce APIs for Orforglipron and Other Drugs